Given their role in drug resistance, GST inhibitors are being explored as a therapeutic strategy to enhance the efficacy of chemotherapy. By inhibiting GST activity, these agents aim to prevent the detoxification of chemotherapeutic drugs, allowing them to remain active within the cancer cells for a longer period. Several GST inhibitors are currently under investigation in preclinical and clinical studies.
